NF-kB inflammation canonical
Selected indexed studies
- The non-canonical NF-κB pathway in immunity and inflammation. (Nat Rev Immunol, 2017) [PMID:28580957]
- Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. (Signal Transduct Target Ther, 2020) [PMID:32958760]
- Enigmatic inflammasomes. (Immunology, 2021) [PMID:33590488]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The non-canonical NF-κB pathway in immunity and inflammation. (2017) pubmed
- Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. (2020) pubmed
- Enigmatic inflammasomes. (2021) pubmed
- A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB. (2019) pubmed
- The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease. (2024) pubmed
- TNF-R1 signaling: a beautiful pathway. (2002) pubmed
- Non-canonical NF-κB contributes to endothelial pyroptosis and atherogenesis dependent on IRF-1. (2023) pubmed
- Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation. (2020) pubmed
- Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway. (2023) pubmed
- Nuclear factor κB overactivation in the intervertebral disc leads to macrophage recruitment and severe disc degeneration. (2024) pubmed